Scientific research & safety

UK-Based Research with Global Impact

At Gill Pharmaceuticals, science, safety, and sustainability guide every aspect of our product development process.

The ICONA range is the result of evidence-based formulation, regulatory precision, and a long-term commitment to advancing patient care in aesthetic medicine.

Our research and development efforts are firmly rooted in the United Kingdom, where we collaborate with leading universities and clinical researchers. These partnerships enable us to conduct independent clinical studies, explore next-generation biomaterials, and translate academic insight into real-world product innovation.

Every formulation is designed to deliver measurable results backed by data, ensuring products are both effective and relevant to the needs of modern aesthetic practitioners.

Pioneering Post-Market Surveillance

Gill Pharmaceuticals is the first company globally to implement a dedicated Post-Market Surveillance (PMS) system specifically for injectable skinboosters therapies. This system provides real-time monitoring of product performance and practitioner feedback, enabling proactive safety measures and continuous product refinement.

Our PMS framework exceeds the basic requirements of the EU Medical Device Regulation (MDR), positioning ICONA as a leader in post-market accountability, patient safety, and regulatory excellence.

Regulatory Excellence and Manufacturing Standards

All ICONA products are:

  • CE2292 certified in compliance with MDR
  • Manufactured in ISO 13485-certified, GMP-compliant facilities
  • Subject to full biocompatibility testing, stability assessments, and batch traceability

This ensures that every unit delivered to a practitioner meets the highest standards of quality, consistency, and safety.

Sustainable by Design

ICONA products are developed with a deep respect for environmental responsibility. All packaging is fully recyclable, and our formulations are:

  • 100% vegan, sterile, and single-use
  • Free from animal-derived ingredients, silicones, and synthetic colourants
  • Designed with sustainability in mind, without compromising clinical performance

Supporting Clinical Confidence

Gill Pharmaceuticals provides complete transparency and support to practitioners through:

  • Clear and detailed ingredient disclosures
  • Comprehensive Instructions for Use (IFUs) with every product
  • Evidence-based training and education programmes to ensure safe, effective application in clinical settings